ATE365321T1 - Verfahren zur erkennung von entzündungen und entzündungsbedingungen - Google Patents
Verfahren zur erkennung von entzündungen und entzündungsbedingungenInfo
- Publication number
- ATE365321T1 ATE365321T1 AT01924324T AT01924324T ATE365321T1 AT E365321 T1 ATE365321 T1 AT E365321T1 AT 01924324 T AT01924324 T AT 01924324T AT 01924324 T AT01924324 T AT 01924324T AT E365321 T1 ATE365321 T1 AT E365321T1
- Authority
- AT
- Austria
- Prior art keywords
- inflammatory conditions
- methods
- detecting inflammation
- inflammatory
- detecting
- Prior art date
Links
- 230000004054 inflammatory process Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000004968 inflammatory condition Effects 0.000 title abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19252900P | 2000-03-28 | 2000-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE365321T1 true ATE365321T1 (de) | 2007-07-15 |
Family
ID=22710051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01924324T ATE365321T1 (de) | 2000-03-28 | 2001-03-27 | Verfahren zur erkennung von entzündungen und entzündungsbedingungen |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20010041177A1 (de) |
| EP (1) | EP1281083B1 (de) |
| JP (1) | JP4777580B2 (de) |
| AT (1) | ATE365321T1 (de) |
| AU (1) | AU2001250987A1 (de) |
| CA (1) | CA2404964A1 (de) |
| DE (1) | DE60129015T2 (de) |
| DK (1) | DK1281083T3 (de) |
| ES (1) | ES2287115T3 (de) |
| WO (1) | WO2001073435A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60140069D1 (de) * | 2000-10-16 | 2009-11-12 | Cytoguide Aps | Funktion eines haptoglobin-hämoglobin-rezeptors und anwendungszwecke dafür |
| US7465555B2 (en) * | 2002-04-02 | 2008-12-16 | Becton, Dickinson And Company | Early detection of sepsis |
| EP1367393A1 (de) * | 2002-05-27 | 2003-12-03 | MacroZyme B.V. | Verfahren zur Verwendung des CD 163 Wegs zur Modulation einer Immunantwort |
| US8116984B2 (en) * | 2004-11-19 | 2012-02-14 | Trillium Diagnostics, Llc | Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64) |
| EP1959956A2 (de) * | 2005-12-15 | 2008-08-27 | Naturemed Group Corporation | Sinomenin-derivate, herstellung davon und verwendungen dafür |
| US20120252041A1 (en) | 2009-10-12 | 2012-10-04 | Region Midjylland | Method of prognosis |
| US20140030735A1 (en) * | 2011-03-07 | 2014-01-30 | Temple University - Of The Commonwealth System Of Higher Education | Biomarkers of chronic obstructive pulmonary disease |
| US11913957B2 (en) | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| CN110114680A (zh) * | 2016-05-05 | 2019-08-09 | 佰欧迪塞克斯公司 | 用于诊断肺癌的组合物、方法和试剂盒 |
-
2001
- 2001-03-27 AT AT01924324T patent/ATE365321T1/de not_active IP Right Cessation
- 2001-03-27 US US09/817,950 patent/US20010041177A1/en not_active Abandoned
- 2001-03-27 JP JP2001571100A patent/JP4777580B2/ja not_active Expired - Fee Related
- 2001-03-27 DK DK01924324T patent/DK1281083T3/da active
- 2001-03-27 DE DE60129015T patent/DE60129015T2/de not_active Expired - Lifetime
- 2001-03-27 CA CA002404964A patent/CA2404964A1/en not_active Abandoned
- 2001-03-27 ES ES01924324T patent/ES2287115T3/es not_active Expired - Lifetime
- 2001-03-27 AU AU2001250987A patent/AU2001250987A1/en not_active Abandoned
- 2001-03-27 WO PCT/US2001/009577 patent/WO2001073435A1/en not_active Ceased
- 2001-03-27 US US10/240,382 patent/US7144710B2/en not_active Expired - Fee Related
- 2001-03-27 EP EP01924324A patent/EP1281083B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1281083T3 (da) | 2007-10-22 |
| US20030215885A1 (en) | 2003-11-20 |
| JP2003529080A (ja) | 2003-09-30 |
| EP1281083A4 (de) | 2004-11-17 |
| DE60129015T2 (de) | 2008-02-21 |
| ES2287115T3 (es) | 2007-12-16 |
| JP4777580B2 (ja) | 2011-09-21 |
| CA2404964A1 (en) | 2001-10-04 |
| WO2001073435A1 (en) | 2001-10-04 |
| EP1281083B1 (de) | 2007-06-20 |
| DE60129015D1 (de) | 2007-08-02 |
| EP1281083A1 (de) | 2003-02-05 |
| US7144710B2 (en) | 2006-12-05 |
| AU2001250987A1 (en) | 2001-10-08 |
| US20010041177A1 (en) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1118005A4 (de) | Verfahren und vorrichtung zur auswertung von halbleiterscheiben | |
| ATE209342T1 (de) | Vorrichtung und verfahren zur gewinnung und erst- aufbereitung von gewebeproben für die molekulargenetische diagnostik | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| EP1075652A4 (de) | Vorrichtung und verfahren zum prüfen von halbleiterscheiben | |
| ATE333517T1 (de) | Verfahren und sondenset zur erkennung von krebs | |
| DE69831917D1 (de) | Verbessertes Verfahren und Vorrichtung zur Waferprobendetektion | |
| DE69535692D1 (de) | Verfahren und Vorrichtung zur automatisierten Prüfung von Photomasken | |
| DE69728017D1 (de) | Vorrichtungen und Verfahren zur Erkennung von mehreren Analyten in Proben | |
| EP1078247A4 (de) | Verbesserte vorrichtung und methode zum durchführen von elektrochemilumineszenz-testmessungen | |
| DE69724037D1 (de) | Verfahren und Vorrichtung zur Erkennung des Inselbetriebs eines Wechselrichters | |
| ATE508630T1 (de) | Verfahren und gerät für das einfrieren und auftauen von biologischen proben | |
| ATE378404T1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
| ATE232559T1 (de) | Verfahren zur signalverstärkung | |
| DE60133982D1 (de) | Biosensor und verfahren zum analysieren von blutkomponenten | |
| ATE444584T1 (de) | Verfahren und anordnung zur ermittlung von zustandsgrössen | |
| DE69932141D1 (de) | Vorrichtung und Verfahren für mikrobiologische Untersuchungen | |
| DE59907067D1 (de) | Polymer-Werkstoff und Herstellungsverfahren, sowie System und Verfahren zur Materialüberprüfung von Polymer-Werkstoffen und Bauteilen | |
| DE69929882D1 (de) | Verfahren und vorrichtung zur nukleinsäurereinigung | |
| DE69932845D1 (de) | Methoden zur quantifizierung von hla-dr und cd11b | |
| DE60235217D1 (de) | Vorrichtung und Verfahren zur Feststellung von Turbomaschinenschaufelschaden | |
| DE69927871D1 (de) | Vorrichtung und Verfahren zur Unterscheidung von Erythrozyten in Urin | |
| DE60217451D1 (de) | Verfahren und Vorrichtung zur Überwachung der Konzentration des Sterilisierungsmittels in diffusionbeschränkten Bereichen | |
| ATE365321T1 (de) | Verfahren zur erkennung von entzündungen und entzündungsbedingungen | |
| DE69726373D1 (de) | Reifenmagnetisierungsmethode, nach dieser Methode magnetisierter Reifen sowie Vorrichtung zur Feststellung von Reifenumdrehungen | |
| DE50010710D1 (de) | Verfahren zur bestimmung von substanzen mittels der evaneszenzfeldmethode |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |